Geron reported $123K in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Amgen AMGN:US $ 6238M 608M
Bio Techne TECH:US $ 290.38M 21.1M
Cytokinetics CYTK:US $ 1.15M 54.45M
Esperion Therapeutics ESPR:US $ 18.84M 3.44M
Exelixis EXEL:US $ 355.98M 95.16M
Genmab GEN:DC DK 2119M 500M
Geron GERN:US $ 0.12M 0.92M
Gilead Sciences GILD:US $ 6590M 654M
Macrogenics MGNX:US $ 11.1M 3.05M
Novartis NOVN:VX SF 12814M 708M
Novavax NVAX:US $ 703.97M 481.77M
Seattle Genetics SGEN:US $ 426.46M 3.39M
YTE INCY:US $ 733.24M 129.62M